Neutral
Penn Capital Management Company LLC trimmed its position in shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 56.1% in the fourth qu...
Neutral
Profund Advisors LLC grew its position in Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 209.3% in the 4th quarter, according to the compan...
Neutral
Profund Advisors LLC increased its stake in shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 209.3% during the fourth quarter, acco...
Bullish
Travere Therapeutics successfully completed a public offering of $525 million in 0.50% Convertible Senior Notes due 2032, generating approximately $50...